Teva Pharmaceutical Industries Limited's ability to collect accounts receivable sequentially worsen to 3.89, pointing to a challenging and on top of that deteriorating business climate for the Major Pharmaceutical Preparations industry. Teva Pharmaceutical Industries Limited's Accounts Receivable average collection period in the Sep 30 2026 quarter, has increased to 94 days, from 93 days, in the Jun 30 2026 quarter.

If we take a look into Healthcare sector 441 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 2894, from overall ranking in the second quarter 2026 at 3325.

What is Receivable Turnover Ratio?
What is Teva Pharmaceutical Industries Limited Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

TEVA Receivables Turnover Ratio	(Sep 30 2026) III. Quarter	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter
Y / Y Receivable Change	0.71 %	-1.99 %	0.27 %	492.49 %	10.05 %
Y / Y Revenue Change	-1.9 %	-0.81 %	2.36 %	-64.55 %	3.44 %
Receivable Turnover Ratio (TTM)	3.89	3.92	3.91	3.88	5.9
TEVA's Total Ranking	# 2894	# 3325	# 2324	# 2316	# 2411
Accounts Receivable average collection period days	94	93	93	94	62
Seq. Receivable Change	9.85 %	2.95 %	-8.52 %	-2.65 %	6.9 %
Seq. Revenue Change	6.11 %	3.99 %	165.53 %	-66.52 %	7.28 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 135
Healthcare Sector	# 442
Overall Market	# 2894

Receivable Turnover Ratio Statistics
High	Average	Low
6.03	4.42	3.08
(Jun 30 2025)		(Sep 30 2011)

TEVA Company Profile • Back to TEVA Efficiency Comparisons • Compare TEVA Receivables Turnover Ratio to its Competitors

Financial Statements
Teva Pharmaceutical Industries Limited's Accounts Receivable	$ 3,837 Millions	Visit TEVA's Balance sheet
Teva Pharmaceutical Industries Limited's Sales TTM	$ 14,020 Millions	Visit TEVA's Income Statement
Sources of TEVA's Revenues		Visit TEVA's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
TEVA's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
TEVA's Growth Rates	TEVA's Roa	TEVA's Inventory Turnover Ratio	TEVA's Dividend Comparisons
TEVA's Profitability Ratios	TEVA's Roi	TEVA's Asset Turnover Ratio	TEVA's Dividend Growth
TEVA's Valuation Ratios	TEVA's Roe	TEVA's Financial Strength Ratios	TEVA's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Sep 30 2026	Receivable at quarter ending Sep 30 2026
Bausch Health Companies Inc	9.15	$ 11,113.000 Millions	$ 1,215.000 Millions
Axogen inc	8.71	$ 266.926 Millions	$ 30.654 Millions
Ensign Group Inc	8.62	$ 5,674.305 Millions	$ 658.477 Millions
Pediatrix Medical Group Inc	8.57	$ 1,959.124 Millions	$ 228.471 Millions
Tenet Healthcare Corp	8.54	$ 22,154.000 Millions	$ 2,593.250 Millions
Brightspring Health Services Inc	8.50	$ 9,479.144 Millions	$ 1,114.763 Millions
Tactile Systems Technology Inc	8.23	$ 357.176 Millions	$ 43.385 Millions
Penumbra Inc	8.22	$ 1,560.334 Millions	$ 189.735 Millions
Inspire Medical Systems inc	8.15	$ 882.194 Millions	$ 108.207 Millions
Alphatec Holdings Inc	7.91	$ 839.652 Millions	$ 106.153 Millions
Exelixis Inc	7.89	$ 2,496.861 Millions	$ 316.636 Millions
Idexx Laboratories Inc	7.78	$ 4,663.675 Millions	$ 599.701 Millions
Merit Medical Systems Inc	7.53	$ 1,612.236 Millions	$ 214.065 Millions
Cerus Corporation	7.48	$ 226.798 Millions	$ 30.308 Millions
Insmed Inc	7.45	$ 1,479.040 Millions	$ 198.502 Millions
Novocure Limited	7.44	$ 725.388 Millions	$ 97.525 Millions
Intuitive Surgical Inc	7.44	$ 12,115.600 Millions	$ 1,629.350 Millions
Quest Diagnostics Inc	7.43	$ 11,841.000 Millions	$ 1,593.250 Millions
Travere Therapeutics Inc	7.32	$ 651.034 Millions	$ 88.900 Millions
Aurinia Pharmaceuticals Inc	7.18	$ 321.738 Millions	$ 44.795 Millions
Beta Bionics Inc	7.15	$ 127.899 Millions	$ 17.897 Millions
Angiodynamics Inc	7.13	$ 323.784 Millions	$ 45.418 Millions
Stryker Corp	6.99	$ 26,300.000 Millions	$ 3,761.500 Millions
Boston Scientific Corporation	6.96	$ 21,070.000 Millions	$ 3,028.750 Millions
Syndax Pharmaceuticals Inc	6.89	$ 289.431 Millions	$ 42.011 Millions
Hca Healthcare Inc	6.85	$ 78,701.000 Millions	$ 11,495.250 Millions
Medpace Holdings Inc	6.73	$ 2,838.385 Millions	$ 421.525 Millions
Carlisle Companies Incorporated	6.67	$ 5,213.500 Millions	$ 781.625 Millions
Iradimed Corporation	6.62	$ 89.340 Millions	$ 13.487 Millions
3m Company	6.59	$ 25,247.000 Millions	$ 3,832.500 Millions

Date modified: 2026-11-04T10:24:57+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.